Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: J Pain. 2019 Apr 18;20(10):1218–1235. doi: 10.1016/j.jpain.2019.04.005

Table 1.

Key Inclusion and Exclusion Criteria

Key Inclusion Criteria Key Exclusion Criteria
Healthy male and female (trial B) adults ≤55 years old with normal blood pressure, pulse, and respiration History of seizures, epilepsy, or recognized increase risk of seizure
Tolerance to cold-induced pain of ≥20 and ≤120 seconds History of cirrhosis or laboratory evidence of liver disease
Negative urine for substances of abuse Known or suspected alcohol or drug abuse within the past 6 months
Normal or intermediate CYP2D6 metabolizer (trial B) Inhibitors of monoamine oxidase, serotonin and/or norepinephrine reuptake, and other medications or supplements known to induce or inhibit drug metabolism or that may affect the serotonergic neurotransmitter system
Adequate hematologic and liver function per predefined limits Ethanol, grapefruit, grapefruit-related citrus fruits (eg, Seville oranges, pomelos), grapefruit-related juices or other new medication
Cockcroft-Gault glomerular filtration rate of ≥60 mL/min and urinalysis with ≤+1 glucose, +1 ketones, and +1 protein Pregnant or breast feeding (trial B)
Body mass index of 18.0–32 kg/m2
If female of childbearing potential, must use adequate contraception
Electrocardiogram without clinically significant changes
Negative serology for HIV, hepatitis B surface antigen, and hepatitis C virus antibody